H79TI087830
Project Grant
Overview
Grant Description
Odmhsas Sosiii - The Oklahoma Department of Mental Health and Substance Abuse Services
ODMHSAS is requesting 15,795,312 for a three year state opioid and stimulant SOS3 initiative, to address the critical public health crisis posed by opioid and other stimulant misuse.
The focus is on three priority areas: prevention, treatment, and recovery support services.
The statewide initiative targets the uninsured, underinsured, and diverse underserved individuals and their families, including Native Americans, tribal communities, persons discharged from incarceration, veterans, pregnant and post partem women, and transitioning youth.
While methamphetamine remains the greatest drug threat in Oklahoma, with the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) reporting 729 methamphetamine-related fatal overdoses in 2022, a 22% increase from the previous year, synthetic opioids and fentanyl-laced counterfeit prescription pills have surged, contributing to 1,721 fatal overdoses in 2022.
The number of overdose deaths involving fentanyl in 2022 was nearly 16 times higher than in 2018.
The Oklahoma SOS3 project will implement a comprehensive continuum of prevention, harm reduction, treatment, and recovery support services, addressing concurrent substance abuse disorders.
The initiative aims to increase community knowledge to prevent opioid and stimulant abuse while enhancing access to services.
It will expand community outreach through training and local action on opioid and stimulant misuse prevention.
Additionally, the program seeks to enhance workforce knowledge and support for individuals at risk or with opioid use disorder (OUD), their families, and the community through training, consultation, and naloxone distribution.
Promoting social and emotional health for students to reduce disruptive behavior and improve instructional time is another key focus.
The initiative will also strengthen community referral networks for individuals with OUD by mobilizing regional resources and increasing access to a range of treatments for OUD and substance use disorders (SUDs), including FDA-approved medications for OUD and stimulant misuse.
To achieve these goals, the SOS program will collaborate closely with treatment providers and institutions serving vulnerable populations.
This partnership aims to educate and empower at risk individuals and their communities by providing overdose prevention education, facilitating treatment referrals, and connecting individuals with local support networks.
By aligning state and grant funding, ODMHSAS will maximize resources, avoid duplication of efforts, and extend services to more individuals and families in need.
ODMHSAS is requesting 15,795,312 for a three year state opioid and stimulant SOS3 initiative, to address the critical public health crisis posed by opioid and other stimulant misuse.
The focus is on three priority areas: prevention, treatment, and recovery support services.
The statewide initiative targets the uninsured, underinsured, and diverse underserved individuals and their families, including Native Americans, tribal communities, persons discharged from incarceration, veterans, pregnant and post partem women, and transitioning youth.
While methamphetamine remains the greatest drug threat in Oklahoma, with the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) reporting 729 methamphetamine-related fatal overdoses in 2022, a 22% increase from the previous year, synthetic opioids and fentanyl-laced counterfeit prescription pills have surged, contributing to 1,721 fatal overdoses in 2022.
The number of overdose deaths involving fentanyl in 2022 was nearly 16 times higher than in 2018.
The Oklahoma SOS3 project will implement a comprehensive continuum of prevention, harm reduction, treatment, and recovery support services, addressing concurrent substance abuse disorders.
The initiative aims to increase community knowledge to prevent opioid and stimulant abuse while enhancing access to services.
It will expand community outreach through training and local action on opioid and stimulant misuse prevention.
Additionally, the program seeks to enhance workforce knowledge and support for individuals at risk or with opioid use disorder (OUD), their families, and the community through training, consultation, and naloxone distribution.
Promoting social and emotional health for students to reduce disruptive behavior and improve instructional time is another key focus.
The initiative will also strengthen community referral networks for individuals with OUD by mobilizing regional resources and increasing access to a range of treatments for OUD and substance use disorders (SUDs), including FDA-approved medications for OUD and stimulant misuse.
To achieve these goals, the SOS program will collaborate closely with treatment providers and institutions serving vulnerable populations.
This partnership aims to educate and empower at risk individuals and their communities by providing overdose prevention education, facilitating treatment referrals, and connecting individuals with local support networks.
By aligning state and grant funding, ODMHSAS will maximize resources, avoid duplication of efforts, and extend services to more individuals and families in need.
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Oklahoma City,
Oklahoma
731066027
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 104% from $15,800,749 to $32,214,595.
Oklahoma Department Of Mental Health And Substance Abuse Services was awarded
OK Opioid & Stimulant Initiative for Public Health Crisis
Project Grant H79TI087830
worth $32,214,595
from the Division of Grants Management in September 2024 with work to be completed primarily in Oklahoma City Oklahoma United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.788 Opioid STR.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Ongoing)
Last Modified 9/26/25
Period of Performance
9/30/24
Start Date
9/29/27
End Date
Funding Split
$32.2M
Federal Obligation
$0.0
Non-Federal Obligation
$32.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to H79TI087830
Additional Detail
Award ID FAIN
H79TI087830
SAI Number
H79TI087830-2661928347
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA Division of Grants Management
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
X5K6JYC467J7
Awardee CAGE
3SBP4
Performance District
OK-03
Senators
James Lankford
Markwayne Mullin
Markwayne Mullin
Modified: 9/26/25